4D Molecular Therapeutics Inc (FDMT)
EBITDA Growth
2.67%
TTM · Period ending:
FDMT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported2.67%period ending
Latest reported2.67%period ending
FDMT TTM EBITDA YoY % (-359.94% → 2.67%)
Year-over-year change
High-resolution chart · PNG
FDMT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 2.6733% | |
| 4.4889% | |
| 8.2302% | |
| -47.2119% | |
| -82.155% | |
| -71.9381% | |
| -62.1267% | |
| -51.7523% | |
| 2.348% | |
| 6.3639% | |
| 8.2286% | |
| 10.1466% | |
| -9.3513% | |
| -37.2066% | |
| -54.323% | |
| -56.29% | |
| -93.2811% | |
| -31.8573% | |
| -21.586% | |
| -25.7489% | |
| 9.0833% | |
| -18.7355% | |
| -23.7501% | |
| -64.9358% | |
| -154.2132% | |
| -211.7628% | |
| -359.9361% |